United States · 
Who invested in Ancora Pharmaceuticals?
Ancora Pharmaceuticals's investors include University Venture Fund.
20082009
?Series A$800KVentureUnited States · Venture startup
Who invested in Ancora Pharmaceuticals
2 rounds we have observed, with the one investor named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.
Follow Ancora Pharmaceuticals and see its new rounds in your feed.Start following
Funding summaryUpdated 31 Oct 2026
$800Kraised across 2 rounds since 2007, from 2 sources
- Latest round
- Venture, $800KNov 2009
- Investors
- 1
The funding story
Each circle is a round, placed by date and sized by amount. The line above is the running total.
- First round
- Series A May 2007
- Biggest round
- $800K Venture · Nov 2009
- Between rounds
- 2.5 years from the last two
The rounds
- Nov 2009Venture$800K
No investor was named in the report.
From a historical funding recordSEC filing: $800K sold, first sale Nov 2009
- May 2007
Everyone who backed them
Missing a round, or an investor who was in one? Tell us.
Quick answers about Ancora Pharmaceuticals
How much has Ancora Pharmaceuticals raised?
Ancora Pharmaceuticals has raised $800K across 2 rounds since 2007. One round did not disclose an amount, so the total is a floor.
When did Ancora Pharmaceuticals last raise?
Ancora Pharmaceuticals's most recent round was a Venture of $800K in Nov 2009.
What was Ancora Pharmaceuticals's biggest round?
Its most recent round, $800K in Nov 2009, is also its largest on record.
Who backed Ancora Pharmaceuticals first?
Ancora Pharmaceuticals's first round on record, in May 2007, was backed by University Venture Fund.
What stage is Ancora Pharmaceuticals at?
Ancora Pharmaceuticals's latest named round is a Venture, in Nov 2009.
Where is Ancora Pharmaceuticals based?
Ancora Pharmaceuticals is based in the United States.
Find investors like these
Search every investor by what they have actually funded, then narrow to your stage and market. Free.